Evidence-Based Complementary and Alternative Medicine

Natural Products for Infectious Diseases


Publishing date
10 Jun 2016
Status
Published
Submission deadline
22 Jan 2016

Lead Editor

1Wonkwang University, Iksan, Republic of Korea

2Hunan University of Chinese Medicine, Changsha, China

3West Virginia University, Morgantown, USA

4Jeonju Biomaterials Institute, Jeonju, Republic of Korea

5University of Cukurova, Adana, Turkey


Natural Products for Infectious Diseases

Description

Infectious diseases have represented a threat to human lives since the beginning of human existence. These infectious diseases were conquered through the discovery of antibiotics and antiviral agents. However, emerging antibiotic-resistant strains and mutant microorganisms are more powerful than the existing antibiotic-resistant strains and mutant microorganisms. In particular, new emerging infectious diseases in the last 20 years have become global issues. Prime examples of these include infections caused by HIV, Ebola, and bird flu viruses, which pose a threat to humans. In addition, the existing microorganisms have developed resistance, leading to infections by antibiotic-resistant Mycobacterium tuberculosis, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant Enterococcus. Moreover, microbial biofilms cannot be treated by antibiotics and can cause chronic infections. Infectious diseases continue to pose a threat to humans and continued efforts are needed to develop effective treatments. In recent times, natural products are as widely used as chemical drugs against clinical diseases. Most chemical drugs that are widely used today were isolated from natural products, and thus natural products will continue to be important raw materials for the development of new drugs. However, since natural products are the byproducts of empirical medicine, they lack scientific validation. Currently, various scientific experiments are being conducted to evaluate the efficacy of natural products.

In vivo or in vitro studies of efficacies of drugs used for infectious diseases, analyses of clinical trial data obtained from scientific statistical investigations, and bioactive components of natural products used for infectious diseases, isolation of chemical components from natural products, and elucidation of mechanism of drug actions are required to evaluate the efficacies of natural products.

The current special issue will include research articles, reviews, and systematic reviews that have evaluated the efficacies of natural products used in traditional or empirical medicine and in suppressing infectious diseases and provide supporting scientific clinical evidence.

Potential topics include, but are not limited to:

  • Clinical trial of natural products for infectious diseases using scientific statistical analysis
  • Animal studies and in vitro experiments evaluating scientific efficacy of natural products used for the treatment of infectious diseases
  • Investigation of pharmacological and molecular biological mechanisms of natural products for infectious diseases
  • The new technologies, such as nanotechnology, novel emulsification methods, and photodynamic therapy, in the formulation of natural products for infectious diseases

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 9459047
  • - Editorial

Natural Products for Infectious Diseases

Kang-Ju Kim | Xiangqian Liu | ... | Serkan Selli
  • Special Issue
  • - Volume 2016
  • - Article ID 1572697
  • - Research Article

Antibacterial and Antibiofilm Activity of Methanolic Plant Extracts against Nosocomial Microorganisms

Eduardo Sánchez | Catalina Rivas Morales | ... | David Mizael Ortiz Martínez
  • Special Issue
  • - Volume 2016
  • - Article ID 2657981
  • - Review Article

Herbal Remedies for Coccidiosis Control: A Review of Plants, Compounds, and Anticoccidial Actions

Thangarasu Muthamilselvan | Tien-Fen Kuo | ... | Wen-Chin Yang
  • Special Issue
  • - Volume 2016
  • - Article ID 5063540
  • - Research Article

Ultrastructural Changes and Death of Leishmania infantum Promastigotes Induced by Morinda citrifolia Linn. Fruit (Noni) Juice Treatment

Fernando Almeida-Souza | Noemi Nosomi Taniwaki | ... | Ana Lúcia Abreu-Silva
  • Special Issue
  • - Volume 2016
  • - Article ID 2396404
  • - Research Article

Chamaecyparis obtusa Suppresses Virulence Genes in Streptococcus mutans

Eun-Hee Kim | Sun-Young Kang | ... | Yong-Ouk You
  • Special Issue
  • - Volume 2016
  • - Article ID 8163150
  • - Research Article

Composition Analysis and Inhibitory Effect of Sterculia lychnophora against Biofilm Formation by Streptococcus mutans

Yang Yang | Bok-Im Park | ... | Yong-Ouk You
  • Special Issue
  • - Volume 2016
  • - Article ID 3948795
  • - Research Article

Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial

Xiao-jin Li | Ru-rong Wang | ... | Gong Cheng
  • Special Issue
  • - Volume 2016
  • - Article ID 2537294
  • - Research Article

Modes of Antiviral Action of Chemical Portions and Constituents from Woad Root Extract against Influenza Virus A FM1

Jia-Hang Su | Rui-Gang Diao | ... | Kefeng Li
  • Special Issue
  • - Volume 2016
  • - Article ID 7083964
  • - Research Article

Antibacterial Activity of Salvadora persica L. (Miswak) Extracts against Multidrug Resistant Bacterial Clinical Isolates

Mohamed Saeed Zayed Al-Ayed | Ahmed Morad Asaad | ... | Abduljabbar Hadi AlMarrani
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate26%
Submission to final decision66 days
Acceptance to publication35 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.